Immunome Inc. (IMNM) Appoints Carol A. Schafer to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. AMD
10. BBIO

Go back to Immunome Inc. (IMNM) Appoints Carol A. Schafer to its Board

Immunome Appoints Carol A. Schafer to Board of Directors

January 2, 2024 8:00 AM EST

BOTHELL, Wash. & EXTON, Pa.--(BUSINESS WIRE)--

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Carol A. Schafer to its Board of Directors. Ms. Schafer has more than 25 years of experience in investment banking and equity capital markets and has served as a corporate director for multiple public companies.

Carols financial expertise, strategic insight and understanding of equity markets will greatly benefit Immunome as we continue to expand and advance our pipeline of targeted oncology... More